The Dipharma Group is a global CDMO and one of the leading family-owned manufacturers of Active Pharmaceutical Ingredients and Intermediates, having a portfolio of more than 40 products, with Drug Master Files lodged worldwide. Dipharma serves top ranking pharmaceutical companies in Europe, U.S.A. and Japan. Supported by a fully equipped R&D Centers, its core technologies are Nitration, Nitroesterification, Azide Chemistry, High Pressure Hydrogenation, Chiral Synthesis, Organometallic Chemistry and Enzymatic Processes.

Chemicals

Life Sciences

Pharmaceutical

Dipharma Francis S.r.l

Andrea Mancini

Lorenzo Brina

Stefano Brambilla

Tiziana Spaccasassi

Fabrizio Losi

Alberto Faido

Mario Cacciatore

Gabriele Razzetti

The Research and Development team at Dipharma Francis S.r.l. is responsible for innovating and optimizing active pharmaceutical ingredients and intermediates. This team utilizes advanced technologies such as nitration, chiral synthesis, and enzymatic processes to develop new products and enhance existing formulations. Additionally, they collaborate closely with quality control and regulatory teams to ensure compliance and strategic advancement in pharmaceutical development.

Research and Development

Procurement and Supply Chain

Research and Development

About

Team members

Other teams at Dipharma Francis S.r.l

Procurement and Supply Chain